摘要:
The present invention is based on the discovery that additional forms of amlodipine besylate exist beyond the single known form of the prior art. The invention also relates to anovel process for making various amlodipine besylate form. The novel amlodipine besylate forms include crystalline hydrates and anhydrates as wellas amorphous forms.
摘要:
A new process to obtain pramipexole and related products is described. The process involves the reaction of new compounds of formula (6), wherein R is hydrogen or acyl group, R3 and R4 are either the same and each of them represents an alkoxy group of 1-4 carbons or they together form a C2-C5 alkylenedioxy group or an oxo-group, with an alkylamine in the presence of a reducing agent or a hydrogen gas with hydrogenation catalyst. A process to obtain new compounds of formula (6) is also described.
摘要:
Process for providing a compound of formula (6), a hydrate, solvate, and/or salt thereof, for example a pharmaceutically acceptable acid addition salt, comprising the step of reacting a compound of formula (1), with a tosyl moiety, providing compound.
摘要:
Process for the preparation of a compound of formula (VI), comprising the steps of: reacting a compound of general formula (I) with a ring-opening agent to provide a compound having general formula (II); protecting the hydroxy groups of the thus formed compound (II) with a pre-determined protective agent in order to substantially retard the reactivity thereof and provide a compound having general formula (III) or (VII), wherein the protective agent retards the reactivity of compound (II) by replacing the hydrogen atom of at least one of the hydroxy groups thereof with a carbon terminated group, whereby, in the case of compound (III) at least one of R?3 and R4¿ is not hydrogen; reacting compound (III) and/or (VII) with an alkylating agent of formula R7X to obtain a compound having formula (IV) or (VIII) respectively, wherein R7 preferably represents a methyl or ethyl group and X represents a halide, preferably chlorine, bromine or iodine; hydrolyzing the protective groups R?3, R4 and R5, R6¿ of compounds (IV) and (VIII) respectively to obtain a compound of formula (V); relactonizing compound (V) to yield compound (VI).
摘要:
Asenapine or a pharmaceutically acceptable salt thereof can be administered intranasally, typically via an intranasal dosage formulation having a water-containing liquid carrier.
摘要:
Process for the preparation of a compound of formula (VI), comprising the steps of: reacting a compound of general formula (I) with a ring-opening agent to provide a compound having general formula (II); protecting the hydroxy groups of the thus formed compound (II) with a pre-determined protective agent in order to substantially retard the reactivity thereof and provide a compound having general formula (III) or (VII), wherein the protective agent retards the reactivity of compound (II) by replacing the hydrogen atom of at least one of the hydroxy groups thereof with a carbon terminated group, whereby, in the case of compound (III) at least one of R?3 and R4¿ is not hydrogen; reacting compound (III) and/or (VII) with an alkylating agent of formula R7X to obtain a compound having formula (IV) or (VIII) respectively, wherein R7 preferably represents a methyl or ethyl group and X represents a halide, preferably chlorine, bromine or iodine; hydrolyzing the protective groups R?3, R4 and R5, R6¿ of compounds (IV) and (VIII) respectively to obtain a compound of formula (V); relactonizing compound (V) to yield compound (VI).
摘要:
The invention relates to a zolpidem salt, excluding the salt zolpidem tartrate exhibiting a melting endotherm corresponding to zolpidem free base upon heating from about 20 °C to about 250 °C at a rate of 5 °C/minute.
摘要:
The present invention is directed towards modified release tablets comprising a tablet matrix having dispersed therein tamsulosin or a pharmaceutically acceptable salt thereof and optionally having an enteric coating over said matrix with a dissolution profile such that in each of the media SIF, FaSSIF, and FeSSIF said tablet releases not more than 60% of said tamsulosin at 2 hours elapsed time in USP 2 apparatus using 500 ml of said media at 50-100 rpm paddle speed.
摘要:
A process for synthesizing a compound of formula (1) comprising the steps of intramolecular esterification, lactonization, of a compound of formula (2) with a lactonization agent in a suitable solvent thus yielding a reaction medium, wherein R is a hydrogen atom or a lower alkyl group, preferably a methyl group and X is a hydrogen atom or a cation, wherein the lactonization agent forms a hydrated complex with water, released on the lactonization of compound (2) into compound (1), which hydrated complex is substantially insoluble in the solvent.
摘要:
The present invention relates to a method for preparing paroxetine of the formula (1) and pharmaceutically suitable salts thereof, comprising the hydrolysis, using a hydrolysing substance, of paroxetine phenyl carbamate of the formula (3) in a solvent composition comprising a sovent which is able to at least partially dissolve the hydrolysing substance.